Cultivate Biologics Logo

Cultivate Research Partnerships

Advancing the Science of Cannabinoids

The Cultivate Health Research Program is foundational in our mission to be the scientific leaders in the field of cannabinoid research, and we know the best way to accomplish this goal is to do so collaboratively. There is a growing body of evidence that extracts from the hemp plant, including cannabinoids and terpenes, have potential health benefits in humans and animals. The potential benefits hold promise in many specific therapeutic areas, in addition to helping maintain general wellbeing. 

There is a large diversity of phytochemicals in the hemp plant, which contains more than 120 different cannabinoids, 200+ potential terpenes, and flavonoids with dramatic variations between strains. Cannabinoid research lies on the cutting edge of science, still offering multiple paths for discovery benefiting human and animal health. With the Endocannabinoid system being discovered in 1992, understanding the biological activity, therapeutic potential, and the possible synergistic or additive effects of these compounds is just beginning. 

Through the Cultivate Health Research Program, we freely provide cannabinoid extracts and formulations for qualified research institutions. The extracts are derived from our proprietary strains of hemp and supported by our technical expertise to ensure successful preclinical and clinical investigator-initiated research projects. We also fund select research studies that support Cultivate Biologics research and development needs.

Learn More About a Partnership Fitting Your Specific Project

Why is it Important for Cultivate Biologics to Fund Research?

Cultivate Biologics believes in the potential of the hemp plant to make a profound impact on human health and we want to accelerate the research process in any way we possibly can. This belief drives our dedication to researching the potential of the hemp plant. We know that cannabinoids and hemp extracts can be expensive and difficult to source with consistency and reliability. Our GMP facilities in Colorado ensure your quality expectations are met. Since Cultivate Biologics owns its own genetics, farming operations, production and manufacturing, we are able to support a wide range of research projects with product at no cost to the research institutions. 

40+

CLINICAL TRIALS & RESEARCH PROJECTS

11

PEER REVIEWED SCIENTIFIC PUBLICATIONS

1 IND & 2 IRB

APPROVALS

GMP 111, 117

QUALITY STANDARDS

Why Apply for the  Program?

Cultivate Biologics is a Leader in Cannabinoid Research 
  • Our formulations have been used in more than 40 clinical trials and R&D projects 
  • 11 peer reviewed scientific publications 
  • Existing partnerships with respected research institutions such as Johns Hopkins Medicine, Washington State University, Cornell, University of Colorado and Oregon State University 
  • Successfully achieved 1 IND and 2 IRB approvals 
Highest Quality and Regulatory Standards  Highest Quality Standards GMP 111, 117
  • Every lot is 3rd party tested 
  • Proprietary strains of hemp that are grown at our facilities in Colorado to ensure year over year consistency of cannabinoid and terpene profiles 
Collaborative Partnerships 
  • We believe that exponentially advancing the research of cannabinoids requires working collaboratively and helping connect and build the community of researchers
  • We provide all of the necessary documentation and consultation required to successfully navigate the IRB process, protocol recommendations, and any additional support that may be needed 
  • We will provide whatever assistance is needed to increase the likelihood of success without jeopardizing research integrity and investigator independence
We are prioritizing partnerships with academic institutions seeking to use Cultivate Biologics proprietary formulations to advance research in the following areas:
  • Joint health
  • Neurological support
  • Benefits for Athletes
  • Brain health
  • GI health
  • Skin health

Speak to a Cultivate Expert About a Research Partnership